Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Aspire-Lakewood Holdings, Inc. (ASBP)

Aspire-Lakewood Holdings: Aspire Biopharma changes name, ticker ASBP unchanged

Neutral Impact 2 of 5 other Written later

Aspire Biopharma Holdings, Inc. announced on September 8, 2026 that it has changed its corporate name to Aspire-Lakewood Holdings, Inc., effective when a Certificate of Amendment is filed in Delaware. The name change was approved by the board and stockholders, and the company says stockholders need not take any action.

Key points

  • Name changed from Aspire Biopharma Holdings, Inc. to Aspire-Lakewood Holdings, Inc., effective upon filing with the Delaware Secretary of State
  • Approved by the board and stockholders under Section 242 of the Delaware General Corporation Law
  • Release says the ticker ASBP is unchanged but also refers to a Nasdaq symbol ASPB, a discrepancy the filing does not resolve
  • No stockholder action required; stock certificates in the prior name remain valid

The filing

CompanyAspire-Lakewood Holdings, Inc. (ASBP)
Form8-K, current report
Filed with the SECSep 8, 2026, 10:10 AM ET
Accession number0001493152-26-041725

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:45 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 08, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.